scholarly journals Surgical benchmarks, mid-term oncological outcomes, and impact of surgical team composition on simultaneous enbloc robot-assisted radical cystectomy and nephroureterectomy

BMC Urology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Stephan Buse ◽  
Assen Alexandrov ◽  
Elio Mazzone ◽  
Alexandre Mottrie ◽  
Axel Haferkamp

Abstract Background Simultaneous urothelial cancer manifestation in the lower and upper urinary tract affects approximately 2% of patients. Data on the surgical benchmarks and mid-term oncological outcomes of enbloc robot-assisted radical cystectomy and nephro-ureterectomy are scarce. Methods After written informed consent was obtained, we prospectively enrolled consecutive patients undergoing enbloc radical cystectomy and nephro-ureterectomy with robotic assistance from the DaVinci Si-HD® system in a prospective institutional database and collected surgical benchmarks and oncological outcomes. Furthermore, as one console surgeon conducted all the procedures, whereas the team providing bedside assistance was composed ad hoc, we assessed the impact of this approach on the operative duration. Results Nineteen patients (9 women), with a mean age of 73 (SD: 7.5) years, underwent simultaneous enbloc robot-assisted radical cystectomy and nephro-ureterectomy. There were no cases of conversion to open surgery. In the postoperative period, we registered 2 Clavien-Dindo class 2 complications (transfusions) and 1 Clavien-Dindo class 3b complication (port hernia). After a median follow-up of 23 months, there were 3 cases of mortality and 1 case of metachronous urothelial cancer (contralateral kidney).The total operative duration did not decrease with increasing experience (r = 0.174, p = 0.534). In contrast, there was a significant, inverse, strong correlation between the console time relative to the total operative duration and the number of conducted procedures after adjusting for the degree of adhesions and the type of urinary diversion(r = -0.593, p = 0.02). Conclusions These data suggest that en bloc simultaneous robot-assisted radical cystectomy and nephro-ureterectomy can be safely conducted with satisfactory mid-term oncological outcomes. With increasing experience, improved performance was detectable for the console surgeon but not in terms of the total operative duration. Simulation training of all team members for highly complex procedures might be a suitable approach for improving team performance. Trial registration: Not applicable.

2014 ◽  
Vol 33 (9) ◽  
pp. 1315-1321 ◽  
Author(s):  
Daniel P. Nguyen ◽  
Bashir Al Hussein Al Awamlh ◽  
E. Charles Osterberg ◽  
James Chrystal ◽  
Thomas Flynn ◽  
...  

2016 ◽  
Vol 34 (2_suppl) ◽  
pp. 426-426
Author(s):  
Shinichi Yamashita ◽  
Akihiro Ito ◽  
Koji Mitsuzuka ◽  
Yoshihide Kawasaki ◽  
Ichiro Shintaku ◽  
...  

426 Background: Most upper urinary tract urothelial carcinomas (UTUC) are invasive and advanced with a poor prognosis. Patients often relapse after treatment with radical nephroureterectomy (RNU). However, little is known about an association between sites of recurrence after RNU and oncological outcomes. The present study retrospectively evaluated the impact of a first recurrence site on survival. Methods: A total of 650 patients with UTUC treated by RNU at 12 institutions that participated in the Tohoku Urological Evidence-Based Medicine Study Group between 2000 and 2011 were initially enrolled. Patients who experienced relapse other than intravesical recurrence after RNU were included in this study. Those who had metastasis at the time of UTUC diagnosis or missing data regarding the time and location of relapse were excluded. Finally, 173 patients were eligible to participate in this study. Survival rates were analyzed using Kaplan-Meier curves and the log-rank test, and factors predicting survival were assessed using multivariate analyses. Results: The median follow-up after relapse was nine months. The cancer-specific survival rates at one and two years after relapse were 49% and 22%, respectively. Cancer in 59 (34%), 32 (18%), 23 (13%), and 94 (53%) patients recurred in the lung, liver, bone and lymph nodes, and 23 (13%) had local recurrence. The one-year cancer-specific survival rates were 44%, 27%, 22% and 52% among patients with metastasis of the lungs, liver, bone and lymph nodes respectively, and 41% among those with local recurrence. The survival rate was worse among 48 patients with metastasis at multiple sites, than in those with metastasis at a single site. Fourteen (8%) patients with a single lymph, lung or local recurrence survived for over three years after a first relapse. Multivariate analyses selected the liver, bone and local recurrence as critical factors for cancer-specific survival. Conclusions: Liver or bone metastasis was a negative prognostic factor for UTUC with relapse after RNU. Information about recurrence sites might be helpful for patient counseling.


2021 ◽  
Vol 8 (4) ◽  
pp. 243-247
Author(s):  
Berk Hazır ◽  
Hakan Bahadır Haberal ◽  
Kadir Emre Baltacı ◽  
Parviz Shahsuvarli ◽  
Bülent Akdoğan ◽  
...  

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
Anojan Navaratnam* ◽  
Kyle Rose ◽  
Haidar Abdul-Muhsin ◽  
Kassem Faraj ◽  
Laila Elias ◽  
...  

2020 ◽  
Vol 11 (4) ◽  
pp. 727-730 ◽  
Author(s):  
Ahmed S. Elsayed ◽  
Naif A. Aldhaam ◽  
Julie Brownell ◽  
Tarik Babar ◽  
Alat Siam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document